Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Chiroscience develops new TNF/PDE IV inhibitors

Nov. 4, 1997

HMR claims dual H1/NK1 antagonists for allergic/inflammatory disorders

Nov. 4, 1997

rPAF-AH proceeds to phase II for asthma

Oct. 31, 1997

HMR reports dual H1/NK1 receptor antagonists

Oct. 30, 1997

Spotlight on tryptase inhibitors for asthma

Oct. 28, 1997

SciClone presents promising preclinical data for CPX at CF conference

Oct. 27, 1997

Potent, topically active glucocorticoid from RPR shows potential for bronchial asthma

Oct. 24, 1997

Abbott develops inhibitors of LT biosynthesis

Oct. 24, 1997

TBC-1269 enters phase II for treatment and prevention of asthma

Oct. 24, 1997

Oxis Turbuhaler launched in U.K.

Oct. 23, 1997

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...